Now researchers are studying them for a surprising range of health conditionsand the findings go well beyond managing type 2 diabetes and obesity
Most mild symptoms improve with slower dose increases, smaller meals, hydration, and close follow-up
Night sweats are not listed as a recognized side effect in FDA prescribing information for GLP-1 receptor agonists
These issues now form the foundation of coordinated legal actions involving Trulicity and other GLP-1 medications: Trulicity is included because it belongs to the same GLP-1 drug class as other medications under scrutiny, and lawsuits claim that class-wide effects on gut motility may be relevant to the injuries alleged
What evidence is needed to strengthen my lawsuit against Trulicity
Shi R, Niu Z, Wu B, et al